USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Norgen Biotek Corp.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.0

Avg claims per patent

+20%

5-year filing velocity

The verdict

Norgen holds 11 US patents across 11 technology areas, rank #24,897 of 50,000 tracked assignees.

#24,897
of 50,000 US assignees by volume: Top 59%
by Innovation Score (32.5/100): 12.0
avg claims per patent: +20%
filing velocity, last 5 yrs

Portfolio overview

Norgen Biotek Corp. has been granted 11 US utility patents between 2015 and 2024, placing Norgen Biotek Corp. at rank #24,897 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.0 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Norgen Biotek Corp. is one of the more focused assignees in the PatentsView dataset. By volume, Norgen sits between Nidec PSA Emotors (11 patents, rank #24,893) and Notal Vision Ltd. (11 patents, rank #24,901) - the closest US assignees by grant volume. The composite Innovation Score of 32.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Norgen Biotek Corp.'s 12.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Norgen Biotek Corp. against peers pursuing similar technology classes.

Nidec PSA Emotors

11
Nikkeikin Alumini…

11
Ningbo Dongchuan…

11
Ningbo Meiying Te…

11
Northeast Institu…

11
Northeast Petrole…

11
Norwood Industries

11
Notal Vision

11
Norgen Biotek ◀

11

What this shows Norgen holds 11 patents at rank #24,897, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Norgen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

33 Top 59% higher than 41% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Norgen Biotek Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	1	9.1%
2017	1	9.1%
2018	1	9.1%
2019	1	9.1%
2020	2	18.2%
2021	1	9.1%
2023	1	9.1%
2024	2	18.2%

Which technologies does Norgen Biotek Corp. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 9

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 8

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 3

C11D - DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL 2

B01D - SEPARATION 2

C09K - MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE 1

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#24,897

Across all tracked assignees

Innovation Score

32.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Norgen Biotek Corp. hold?

Norgen Biotek Corp. holds 11 US granted patents filed between 2015 and 2024, spanning 11 technology areas.

What is Norgen Biotek Corp.'s Innovation Score?

Norgen Biotek Corp. has an Innovation Score of 32.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Norgen Biotek Corp. focus on?

Norgen Biotek Corp.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 9 patents. The company has filed patents in 11 CPC subclasses total.

Is Norgen Biotek Corp.'s patent filing rate increasing or decreasing?

Norgen Biotek Corp.'s recent filing velocity is +20% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Norgen Biotek Corp.'s patents?

Norgen Biotek Corp.'s patents average 12.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Norgen Biotek Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Norgen's 11 grants land it in the top 59% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Norgen ranks #24,897 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.